Navigation Links
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2011 Financial Results
Date:10/31/2011

ira announced that it had entered into agreements with Quintiles Commercial US, Inc. (Quintiles) and Integrated Commercialization Services, Inc. (ICS) to support the anticipated launch of EXPAREL.
  • Presented at the 38th Annual Meeting & Exposition of the Controlled Release Society (CRS). In August 2011, Pacira presented new preclinical data evaluating the safety of DepoFoam, the Pacira proprietary, extended-release drug delivery technology, during two podium sessions at CRS in National Harbor, Md.

  • Financial Highlights

  • Net loss for the third quarter ended September 30, 2011 was $9.5 million, or $0.55 per share (based on 17.2 million weighted average shares outstanding), compared with $7.9 million, or $13.77 per share, for the quarter ended September 30, 2010 (based on 0.6 million weighted average shares outstanding). The difference in the number of weighted average shares outstanding primarily resulted from the Pacira initial public offering (IPO) in February 2011, as well as the conversion of all preferred stock and the principal and accrued interest on certain notes into common stock upon closing of the IPO.
  • Total revenues for the quarter ended September 30, 2011 were $4.0 million compared with $4.5 million for the third quarter of 2010. The decrease was primarily attributable to a $1.1 million decline in supply revenue which reflects fewer lot sales to Pacira's commercial partners. This was offset by a $0.6 million increase in collaborative licensing and development revenue which was principally driven by activities performed under the license agreement Pacira has with Novo Nordisk that was executed in the first quarter of 2011.
  • Total operating expenses for the quarter ended September 30, 2011 were $12.7 million compared with $11.0 million for the same period of 2010. The $1.7 million increase was primarily attributable to expenses related to pre-commercialization activities performed in anticipation o
    '/>"/>

  • SOURCE Pacira Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
    2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
    3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
    4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
    5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
    6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
    7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
    8. Pacira Pharmaceuticals EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
    9. Pacira Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference
    10. Pacira Pharmaceuticals Reports Fourth Quarter and 2010 Financial Results
    11. Pacira Pharmaceuticals to Present at BioCentury Future Leaders in the Biotech Industry Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2014)... In conjunction with DURECT Corporation,s (Nasdaq: ... release, you are invited to listen to the conference ... on Thursday, August 7, 2014 at 4:30 pm Eastern ... audio webcast of the presentation will be available by ... "Investor Relations."  If you are unable to participate during ...
    (Date:7/30/2014)... , July 30, 2014 The ... Care Pharmacy (AMCP) last evening expressed support for ... the Joint Commission of Pharmacy Practitioners (JCPP).  As ... organizations over a two-year period to develop a ... pharmacists.  "Pharmacists are fast becoming ...
    (Date:7/30/2014)... 2014 Research and Markets has announced the ... to 2019" report to their offering. ... grow at a lower CAGR in developed countries; however, it is ... China , India , and ... The growth of the hematology analyzers and reagents market is driven ...
    Breaking Medicine Technology:DURECT Corporation Invites You to Join its Second Quarter 2014 Earnings Conference Call 2AMCP Endorses JCPP "Pharmacists' Patient Care Process" 2Hematology Analyzers & Reagents Market - Forecasts to 2019 2
    ... Georgia has announced the details of their Prostate Cancer ... Georgia in January.  These courses enable the public to become ... All Prostate Cancer Lecture Series seminars are offered free to ... p.m. followed by a lecture at 5:30 p.m. Classes are ...
    ...  A group of 22 bipartisan House Members yesterday wrote ... asking the agency to stop their prepayment review project ... beneficiaries. The lawmakers, who included Rep. Bill ... job losses, restricted access to mobility equipment for Medicare ...
    Cached Medicine Technology:Radiotherapy Clinics of Georgia Present Prostate Cancer Lecture Series 2Bipartisan Group of 22 House Members ask CMS to Stop Prepayment Review Project that would Jeopardize Care for Medicare Beneficiaries 2Bipartisan Group of 22 House Members ask CMS to Stop Prepayment Review Project that would Jeopardize Care for Medicare Beneficiaries 3
    (Date:7/30/2014)... DC (PRWEB) July 30, 2014 Nationally ... RN, CNE, ANEF, who since September 2013 has served ... , became the new dean of the College of ... The move marries her leadership of the NLN, as ... of the top-ranked academic nursing and research institutions in ...
    (Date:7/30/2014)... Bentonville, AR (PRWEB) July 30, 2014 ... providing their patients with free oral cancer screenings. Using ... team will work to detect the disease in its ... the lips, tongue, cheek, mouth, sinuses, throat and other ... National Cancer Institute’s Surveillance, Epidemiology, and Ends Results (SEER) ...
    (Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, ... likely to develop dementia, but researchers have been unable to ... Specifically, they haven,t been able to figure out the ... bring on dementia, or does dementia cause people to become ... the journal Neurology sheds more light on the ...
    (Date:7/30/2014)... July 30, 2014 Good Neighbor ... in an upcoming episode of Innovations with Ed ... Channel. Dates and show times TBA. , In ... Neighbor Community Services’ vision to redefine the traditional ... and dynamic services. Through passion, innovation, determination, excellence, ...
    (Date:7/30/2014)... Volunteers from the Church of Scientology ... this summer with massive distribution of Truth About ... these volunteers on Strøget, the famous Copenhagen walking street. ... shopping and its ambiance, some quarter of a million ... day. , These activities are part of a ...
    Breaking Medicine News(10 mins):Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 2Health News:National League for Nursing Congratulates League President Marsha Adams on Appointment as Dean of College of Nursing at University of Alabama-Huntsville 3Health News:Restore Dental Offers Complimentary Oral Cancer Screenings in August 2Health News:Scientists Shed Light on Link Between Depression, Dementia 2Health News:Scientists Shed Light on Link Between Depression, Dementia 3Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2
    ... Fostering innovation to speed the improvement of health care ... researchers at Cincinnati Children,s Hospital Medical Center. "The ... broken," says Peter Margolis, MD, PhD, co-Principal Investigator of ... our previous successes, is to create a totally new ...
    ... , , , ... today that it has changed its corporate name to Ocular Therapeutix, ... more clearly articulates our mission in the ophthalmic marketplace as we ... and develop ocular drug delivery therapies." , , ...
    ... the psychological distress and burnout experienced by many physicians ... Center researchers report in today,s issue of the ... ). The training also can expand a physician,s ... according to the researchers, who were led by Michael ...
    ... , Former Vermont Governor to sign new book ... Sept. 23 -- Governor Howard Dean will be in Philadelphia, PA and ... and sign copies of his new book, Howard Dean,s Prescription for Real ... at the Philadelphia Free Library for a noon book signing and discussion. ...
    ... , , , , ... & Lione, one of the largest intellectual property law firms in the U.S., ... its long-time client Cook Incorporated in a patent infringement case brought by Edwards ... Appeals for the Federal Circuit affirmed the previous ruling of the U.S. District ...
    ... though, that biggest risk factor is the brain attack itself ... reduce the chances of developing dementia such as Alzheimer,s disease ... concentrating on all the known stroke risk factors, a new ... analysis of 30 previous studies that involved more than 7,500 ...
    Cached Medicine News:Health News:Open innovation networks are one key to improved care 2Health News:Open innovation networks are one key to improved care 3Health News:Open innovation networks are one key to improved care 4Health News:Open innovation networks are one key to improved care 5Health News:Mindful meditation, shared dialogues reduce physician burnout 2Health News:Mindful meditation, shared dialogues reduce physician burnout 3Health News:Mindful meditation, shared dialogues reduce physician burnout 4Health News:Brinks Hofer Gilson & Lione Wins Patent Appeal for Cook Incorporated 2Health News:Brinks Hofer Gilson & Lione Wins Patent Appeal for Cook Incorporated 3Health News:Preventing Second Stroke May Stave Off Dementia 2Health News:Preventing Second Stroke May Stave Off Dementia 3
    ... flow while minimizing the pain ... the safety-engineered BD Microtainer Genie ... Lancet offers a full range ... capillary blood collection and protects ...
    ... Maximize blood flow and minimize pain ... the safety-engineered BD Microtainer Quikheel Lancet. ... surgical blade providing a precise and ... retracts into its casing, helping to ...
    DAVINCI® performs all required steps primary tube sampling, reagent dispensing, microplate incubation, washing and optical reading....
    The Minilyser offers a combination of three well proven instruments for fully automated processing of microplates. The Minilyser is the optimal fully automated ELISA and EIA equipment for laboratorie...
    Medicine Products: